Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve Unaudited Financial ....
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has informed the stock exchanges that its Board of Directors will meet on Thursday, 31 July 2025. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2025, i.e., Q1 FY2026. As a regulatory requirement, the trading window for insiders is already closed from 1 July 2025 and will reopen on 2 August 2025. This is a standard pre-results intimation filed under SEBI Listing Regulations. No financial figures or business details have been disclosed in this filing.
This is a routine regulatory announcement with no direct impact on the stock price. Investors should mark 31 July 2025 on their calendar, as the actual Q1 results announced that day will determine the stock's next move.